These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24935473)
1. Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer. Wang TY; Huang YP; Ma P Tumour Biol; 2014 Sep; 35(9):9255-62. PubMed ID: 24935473 [TBL] [Abstract][Full Text] [Related]
2. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer. Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population. Mu YP; Su XL Med Oncol; 2012 Sep; 29(3):1723-32. PubMed ID: 22108846 [TBL] [Abstract][Full Text] [Related]
4. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer. Wang J; Shi Y; Wang G; Dong S; Yang D; Zuo X Mol Genet Genomic Med; 2019 Aug; 7(8):e804. PubMed ID: 31297985 [TBL] [Abstract][Full Text] [Related]
5. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes. Li X; Zhang R; Liu Z; Li S; Xu H Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632 [TBL] [Abstract][Full Text] [Related]
6. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival. Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428 [TBL] [Abstract][Full Text] [Related]
7. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women. Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022 [TBL] [Abstract][Full Text] [Related]
8. Association of a potential functional mir-520f rs75598818 G>A polymorphism with breast cancer. Meshkat M; Mesrian Tanha H; Ghaedi K; Meshkat M J Genet; 2018 Dec; 97(5):1307-1313. PubMed ID: 30555079 [TBL] [Abstract][Full Text] [Related]
9. Evi-1 as a critical regulator of leukemic cells. Goyama S; Kurokawa M Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840 [TBL] [Abstract][Full Text] [Related]
10. The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review. Pan W; Cheng H; Zhang J; Yang Z; Lin M Clin Breast Cancer; 2024 Aug; 24(6):552-561. PubMed ID: 38641470 [TBL] [Abstract][Full Text] [Related]
11. The impact of mitochondria-related Golubickaite I; Ugenskiene R; Korobeinikova E; Gudaitiene J; Vaitiekus D; Poskiene L; Juozaityte E Biomarkers; 2021 Jun; 26(4):343-353. PubMed ID: 33715547 [TBL] [Abstract][Full Text] [Related]
12. Association between Genetic Polymorphisms of miR-1307, miR- 1269, miR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women. Sarabandi S; Sattarifard H; Kiumarsi M; Karami S; Taheri M; Hashemi M; Bahari G; Ghavami S Asian Pac J Cancer Prev; 2021 Jan; 22(1):201-208. PubMed ID: 33507700 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer. Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476 [TBL] [Abstract][Full Text] [Related]
15. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies. Goyama S; Kurokawa M Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome. Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300 [TBL] [Abstract][Full Text] [Related]
17. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia. Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451 [TBL] [Abstract][Full Text] [Related]
18. Expression of the zinc finger gene EVI-1 in ovarian and other cancers. Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329 [TBL] [Abstract][Full Text] [Related]
19. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population. Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849 [TBL] [Abstract][Full Text] [Related]
20. The role of base excision repair in pathogenesis of breast cancer in the Polish population. Cuchra M; Mucha B; Markiewicz L; Przybylowska-Sygut K; Pytel D; Jeziorski A; Kordek R; Majsterek I Mol Carcinog; 2016 Dec; 55(12):1899-1914. PubMed ID: 27870262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]